Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL328P is a human pseudogene classified as "RNA, 7SL, cytoplasmic 328, pseudogene." It is a truncated, non-protein-coding genomic sequence derived from the 7SL RNA gene, which itself encodes the RNA component of the signal recognition particle (SRP) involved in protein targeting to the endoplasmic reticulum[6][1][3][5]. RN7SL pseudogenes are widespread in the human genome and generally result from reverse transcription and genomic integration events[3][5]. Unlike functional SRP genes, RN7SL328P does not produce a functional transcript and is not known to participate in cellular biology, signaling, or disease. Most 7SL-related pseudogenes, including RN7SL328P, have no documented biological or pathological role; although some transcribed pseudogenes may have indirect effects on gene expression through the microRNA/ceRNA network, this is not recorded for RN7SL328P[2], and it remains a noncanonical, non-functional sequence in standard gene annotation databases[6][1][3][4][5].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 328, pseudogene (RN7SL328P).